Avance Clinical Archives | Be Korea-savvy

Home / Posts tagged Avance Clinical

Avance Clinical CEO and Asia Director Sign MOUs with Key Clinical Trial Sites in Korea around 2024 KoNECT

WAKE FOREST, N.C. and ADELAIDE, Australia , Oct. 29 (Korea Bizwire) – Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce the signing of three significant Memorandums of Understanding (MOUs) with key Korean clinical sites during KoNECT 2024 conference. Avance Clinical CEO Yvonne [...]

Avance Clinical Joins the Australian Clinical Trials Roadshow, Sharing Cost and Time Benefits for Early-Phase US Biotechs

WAKE FOREST, N.C. and ADELAIDE, Australia, Sept. 13, 2024 (Korea Bizwire) – Avance Clinical, the market-leading CRO for biotechs, announced today that Avance Clinical will represent the CRO sector at the Australian Clinical Trials Roadshow (September 17-20) to share the unparalleled time, cost and quality opportunities for early phase US biotechs. Register Here Key Avance Clinical Australia [...]

Avance Clinical Wins 2024 Frost & Sullivan Award for Global Biotech CRO Excellence

ADELAIDE, Australia and WAKE FOREST, N.C., Aug. 27, 2024 (Korea Bizwire) – Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence. Avance Clinical CEO Yvonne Lungershausen thanked Frost & Sullivan for the global award [...]

Avance Clinical Announces Senior Appointment to North American Operations

ADELAIDE, Australia and WAKE FOREST, N.C., July 31, 2024 (Korea Bizwire) – Avance Clinical, an award-winning, mid-sized full-service global Contract Research Organization (CRO) for biotech companies, is pleased to announce the appointment of Jeanne Schow as Senior Vice President, Business Development. Jeanne will be based out of the San Francisco Bay Area. Meet Jeanne Schow and the [...]